Clinical Trial: A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07751848) titled 'A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus' on July 21.

Brief Summary: This study aims to describe clinical outcomes, with focus on remission, achieved with use of anifrolumab participants with SLE on standard-of-care (as recommended by 2025 China SLE guidelines). Further, it aims to describe outcomes alongside a systematic approach to glucocorticoid (GC) tapering, in terms of effectively minimising GC use, as well as discontinuing GC use, thereby reducing GC exposure.

Study Start Date: Sept. 04

Study Type: INTERVENTIONAL

Condition: Lupus Erythematosus,...